3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Rectal Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Neoplasm, Residual
2
Mesothelioma, Malignant
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Solitary Fibrous Tumor, Pleural
1
Sarcopenia
1
Sarcoglycanopathies
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Microsatellite Instability
1
Mesothelioma
1
Melanoma
1
Malnutrition
1
Lung Neoplasms
1
HER2 Negative Breast Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Frailty
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
Doxorubicin
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
CTLA-4 Antigen
3
Biopsy
3
cabozantinib
2
Ifosfamide
2
tremelimumab
1
talimogene laherparepvec
1
regorafenib
1
peposertib
1
pazopanib
1
olaratumab
1
liposomal doxorubicin
1
futibatinib
1
fludarabine
1
eribulin
1
durvalumab
1
avelumab
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Standard of Care
1
Quality of Life
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Chemotherapy, Adjuvant
×
1 year
×
Clear all
No trials found.